PARNAX LAB
Back to Balance Sheet
|
PARNAX LAB Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹74 Cr | ₹83 Cr | ₹63 Cr | ₹81 Cr | ₹54 Cr |
What is the latest Total Current Liabilities ratio of PARNAX LAB ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹74 Cr |
| Mar2024 | ₹83 Cr |
| Mar2023 | ₹63 Cr |
| Mar2022 | ₹81 Cr |
| Mar2021 | ₹54 Cr |
How is Total Current Liabilities of PARNAX LAB Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹74 Cr | -10.79 | |
| Mar2024 | ₹83 Cr | 32.18 | |
| Mar2023 | ₹63 Cr | -22.15 | |
| Mar2022 | ₹81 Cr | 48.93 | |
| Mar2021 | ₹54 Cr | - | |
Compare Total Current Liabilities of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹144.6 Cr | 1.3% | -1.8% | -21.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | 1.3% |
-1.8% |
-21.6% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses